Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
US8962652B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8962652-B2 |
| Application number | US-201014006649-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2010 |
| Priority date | Oct 22, 2009 |
| Publication date | Feb 24, 2015 |
| Grant date | Feb 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present application includes novel modulators of TLRs, compositions containing such compounds, therapeutic methods that include the administration of such compounds.
First claim
Opening claim text (preview).
We claim: 1. A compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein: L 1 is —O—; R 1 is H, C 1-6 alkyl, C 1-6 heteroalkyl, or C 4-20 heterocyclylalkyl, wherein each heteroalkyl group includes 1 or 2 heteroatoms selected from O, N, or S, and wherein each heterocyclyl group includes 1 to 6 heteroatoms selected from O, N, or S;…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8962652B2 cover?
- The present application includes novel modulators of TLRs, compositions containing such compounds, therapeutic methods that include the administration of such compounds.
- Who is the assignee on this patent?
- Halcomb Randall L, Roethle Paul, Gilead Sciences Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/437. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).